- Specialization
- Speech
- Business
- Software Applications
- Market
- Healthcare
- Ecosystem
- Applications
- Customers
Enterprisesand 1 more customers valuesLess
- Small Businesses
More details
- Organization type
- Commercial Company
- Ecosystem
- Applications
- Business
- Software Applications
- Specialization
- Speech
- Market
- Healthcare
- Customers
- Enterprises, Small Businesses
- Delivery models
- Hosted Software, API
- Revenue models
- Subscription, Licensing
- Listing status
- Not classified
- Latest equity round
- Not classified
- Reported funding amount
- $50M-$200M
About
Suki builds ambient clinical-intelligence software for clinicians, healthcare organizations, EHR partners, and digital-health companies. Its flagship Suki Assistant listens to patient-clinician conversations to generate documentation, while also supporting coding, clinical questions, orders, billing, and patient communication; its differentiation is deep, real-time EHR integration and a partner-facing AI and speech platform.
Market
Suki competes in the ambient clinical intelligence and healthcare AI market, particularly AI-powered clinical documentation, medical scribing, coding, and workflow automation. It positions itself as an enterprise-grade platform that goes beyond transcription: its ambient intelligence layer is embedded at the point of care, integrates with major EHRs, supports documentation and revenue-cycle workflows, and is available to partners through SDKs and APIs. Its main competitive set includes Abridge, Microsoft Nuance, Ambience Healthcare, Commure, DeepScribe, Nabla, and Heidi Health.
Suki primarily targets enterprise healthcare organizations, including health systems, clinical practices, clinicians, and health-plan care-management teams that want to automate documentation and related workflows within existing EHR environments. It also targets healthcare technology companies seeking to embed ambient clinical intelligence through Suki's SDKs and APIs.
At a Glance
Problem
Suki addresses the administrative burden of clinical documentation, which keeps clinicians away from patients and contributes to burnout. The pain is substantial: clinicians reportedly spend only 27% of their day with patients, with the remainder lost to manual charting and documentation. The main use case is capturing the patient visit without requiring the clinician to type notes afterward, reclaiming time and clinical capacity.
The economic value is faster documentation, less after-hours administrative work, and potentially better operational performance for providers and health systems. Suki reports that clinicians complete notes 41% faster on average, while its broader positioning links reduced documentation burden with more time for patients and lower burnout.
Product / Service
Suki Assistant is an ambient AI clinical assistant that listens to patient–clinician conversations and uses generative AI to create clinical documentation automatically. Its clinician offering also supports ambient note generation, ICD-10 coding, clinical questions and answers, and integration with electronic health records, allowing the assistant to fit into existing workflows rather than operating as a standalone note-taking tool.
Suki also provides a developer platform, including SDKs and APIs, so healthcare technology companies and EHR vendors can embed Suki’s voice and AI capabilities into their own products. The benefit is an end-to-end workflow that helps clinicians document, code, navigate the EHR and retrieve information with less manual effort.
Market
Suki competes in healthcare AI, particularly the ambient clinical intelligence, AI medical scribe and voice-enabled clinical-assistant categories. Its target customers include physicians, hospitals, health systems, EHR vendors and healthcare technology companies. The available evidence does not identify specific named competitors, so Suki is best positioned here by category rather than by a verified competitor set.
The company appears commercially deployed rather than pre-revenue: it was founded in 2017, reports trust from more than 400 health systems, says it integrates with all major EHRs, and has expanded partnerships across health systems, health-tech companies and EHR solutions. It has also raised $70 million to build out its AI assistant technology. Suki remains a private, non-publicly traded company, and the available evidence does not provide audited revenue or pricing information.
Founders & Leadership
Funding History
Venrock, First Round Capital
Venrock
Flare Capital
March Capital
Hedosophia
Zoom Ventures
Recent News
Suki announced $90 million in Series E financing on October 13 to accelerate growth and expand its healthcare AI capabilities. New investors include Healthier Capital, Crosslink Capital, and Hercules Capital; Aman Mahajan of Healthier Capital will join Suki’s board.
Suki announced the availability of Ask, a clinical decision-support feature that lets clinicians query patient-specific information and access evidence-based answers powered by Wolters Kluwer’s UpToDate Expert AI. The feature was made available across Epic, Oracle Health, athenahealth, and MEDITECH workflows.
Suki launched the “Science at Suki” research initiative to publicly share its work on ambient clinical intelligence. The initiative will produce articles, interviews, videos, white papers, and peer-reviewed publications focused on product development, engineering, and implementation impact.
On August 25, 2026, Suki launched Suki Dictation, an AI clinical documentation tool. The product enables clinicians to dictate and edit documentation by voice, integrates with Epic and MEDITECH electronic health records, and can be deployed standalone or alongside Suki’s ambient documentation technology.
Suki and Teladoc Health announced a partnership to embed Suki’s ambient clinical AI directly into Teladoc’s Solo Virtual Care Platform. The integration generates clinical documentation within clinicians’ existing workflows and extends AI support to virtual nursing assessments, including admission, discharge, and other nursing workflows.
Suki positioned its product as more than an AI scribe, emphasizing clinical-context understanding, EHR integration, and user trust. The announcement says the system is trusted by more than 80% of users.
HealthEdge and Suki announced an integration of Suki with HealthEdge GuidingCare for care-management workflows. The partnership is intended to automate work for care managers, reduce administrative burden, and elevate care delivery.
Suki highlighted how ambient AI can go beyond note-taking to help clinicians remain present with patients. The post frames Suki’s technology as supporting a more human-centered clinical experience.
Suki announced a nursing consortium with leading health systems to develop AI intended to reduce nurses’ administrative burden. The initiative includes work on Suki for Nurses.
Active Roles
11Business Model
Suki monetizes subscriptions and enterprise contracts for Suki Assistant, with third-party pricing references indicating approximately $299-$399 per user per month and custom enterprise pricing. It also licenses or commercializes Suki Platform, its AI and speech infrastructure, through partnerships with healthcare technology companies and EHR platforms.
Products
Customers
Tech Stack
Similar Companies
Competitors
Key Investors
Zoom Ventures, Hedosophia, March Capital, Venrock, First Round Capital, Flare Capital Partners, Breyer Capital